JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tayek, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tayek, J. A.

Journal of the American College of Nutrition, Vol 15, Issue 2 164-168, Copyright © 1996 by American College of Nutrition


JOURNAL ARTICLE

Effects of tumor necrosis factor alpha on skeletal muscle amino acid metabolism studied in-vivo

J. A. Tayek
Department of Medicine, UCLA, School of Medicine, Harbor-UCLA Medical Center, Torrance, USA.

OBJECTIVE: The present study was performed to determine the chronology of the effects of a single 50 ug subcutaneous dose of TNF on food intake, weight gain, and skeletal muscle protein metabolism in normal rats. Earlier work demonstrated that a single subcutaneous dose of 50 ug of tumor necrosis factor alpha (TNF) significantly increased skeletal muscle protein synthesis and breakdown in the tumor bearing rat [1]. Some of the earlier work demonstrated that TNF can reduce food intake, weight gain and enhance muscle catabolism. DESIGN: Twenty-five male Sprague Dawley rats were randomized assigned to treatment or saline arms of the study. Rates of in vivo incorporation of L-1-14C-leucine into skeletal muscle were measured by the flooding dose technique. Rats were studied 6 and 60 hours after TNF or saline. RESULTS: Six hours after administration of the TNF, the total skeletal muscle amino acid concentration was significantly reduced by 20%. The greatest reductions were seen in lysine, arginine, and isoleucine (39-53%) followed by serine, tyrosine, ornithine, threonine and alanine (18-32%). Despite this drop in skeletal muscle amino acid concentrations, the rate of skeletal muscle protein synthesis was similar to the controls (12.2 +/- 4.1 vs 13.8 +/- 3.7 %/day, mean +/- sd, saline vs TNF treated, respectively). Dietary intake (8.2 +/- 0.5 vs 7.3 +/- 1.1 g/day) and weight gain (7.1 +/- 1.1 vs 9.1 +/- 3.8 g/day) were not affected by TNF administration. However, there was a significant increase in skeletal muscle protein synthesis rate in the TNF treated group after 60 hours (17.8 +/- 4.0 vs 12.2 +/- 4.1 %/day) but not after 6 hours (13.8 +/- 3.7 vs 13.7 +/- 3.3 %/day) compared to saline treated rats, respectively. TNF administration after 60 hours was not associated with an elevated skeletal muscle 3-methyl-histidine concentration or a reduced nitrogen balance. CONCLUSION: These data suggest that at a 50 ug subcutaneous dose of TNF, an early (6 hours) effect is to reduce skeletal muscle of amino acids without effecting either synthesis or breakdown. A later effect (60 hours) is to normalize skeletal muscle amino acid concentration and to increase skeletal muscle protein synthesis. This suggests that TNF may acutely alter amino acid transport as one of its modes of action.


This article has been cited by other articles:


Home page
ThoraxHome page
D. D Sin and W D. Reid
Is inflammation good, bad or irrelevant for skeletal muscles in COPD?
Thorax, February 1, 2008; 63(2): 95 - 96.
[Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
M. M. McDermott, K. Liu, J. M. Guralnik, L. Ferrucci, D. Green, P. Greenland, L. Tian, M. H. Criqui, C. Lo, N. Rifai, et al.
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and d-dimer.
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2006; 61(4): 374 - 379.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. M. McDermott, P. Greenland, J. M Guralnik, L. Ferrucci, D. Green, K. Liu, M. H Criqui, J. R Schneider, C. Chan, P. Ridker, et al.
Inflammatory markers, D-dimer, pro-thrombotic factors, and physical activity levels in patients with peripheral arterial disease
Vascular Medicine, May 1, 2004; 9(2): 103 - 105.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Biolo, R. Y. D. Fleming, S. P. Maggi, T. T. Nguyen, D. N. Herndon, and R. R. Wolfe
Inverse Regulation of Protein Turnover and Amino Acid Transport in Skeletal Muscle of Hypercatabolic Patients
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3378 - 3384.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
M. Visser, M. Pahor, D. R. Taaffe, B. H. Goodpaster, E. M. Simonsick, A. B. Newman, M. Nevitt, and T. B. Harris
Relationship of Interleukin-6 and Tumor Necrosis Factor-{alpha} With Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC Study
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): M326 - 332.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y.-P. Li and M. B. Reid
NF-kappa B mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1165 - R1170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. H. Lang, R. A. Frost, A. C. Nairn, D. A. MacLean, and T. C. Vary
TNF-alpha impairs heart and skeletal muscle protein synthesis by altering translation initiation
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E336 - E347.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Nutrition.